Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection-Reference-Cited by-同舟云学术

Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection

Published:2016-10-26 Issue:8 Volume:47 Page:773-782
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Morishita Naoki¹,Hiramatsu Naoki¹,Oze Tsugiko¹,Urabe Ayako¹,Tahata Yuki¹,Yamada Ryoko¹,Yakushijin Takayuki¹,Hosui Atsushi²,Iio Sadaharu³,Yamada Akira⁴,Hagiwara Hideki⁵,Mita Eiji⁶,Yamada Yukinori⁷,Ito Toshifumi⁸,Inada Masami⁹,Katayama Kazuhiro¹⁰,Yabuuchi Iwao¹¹,Imai Yasuharu¹²,Hikita Hayato¹^ORCID,Sakamori Ryotaro¹,Yoshida Yuichi¹,Tatsumi Tomohide¹,Hayashi Norio⁵,Takehara Tetsuo¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Osaka University Graduate School of Medicine; Suita Japan

2. Osaka Rosai Hospital; Sakai Japan

3. Higashiosaka City General Hospital; Higashiosaka Japan

4. Sumitomo Hospital; Osaka Japan

5. Kansai Rosai Hospital; Amagasaki Japan

6. National Hospital Organization Osaka National Hospital; Osaka Japan

7. Kaizuka City Hospital; Kaizuka Japan

8. Japan Community Health Care Organization Osaka Hospital; Osaka Japan

9. Toyonaka Municipal Hospital; Toyonaka Japan

10. Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka Japan

11. National Hospital Organization Minami Wakayama Medical Center; Tanabe Japan